Upcoming events on Protalix BioTherapeutics, Inc.

No events available

Past events on Protalix BioTherapeutics, Inc.

12/08/2026

Earnings presentation

15:00
12/08/2026

Earnings release - Q2 2026

25/06/2026

Annual General Meeting

15:00
13/05/2026

Earnings release - Q1 2026

13/05/2026

Earnings presentation

15:00
18/03/2026

Earnings release - Annual 2025

18/03/2026

Earnings presentation

15:00
13/11/2025

Earnings presentation

16:00
13/11/2025

Earnings release - Q3 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
65,5
64,0
2.41%
53,4
53,9
-0.98%
52,7
58,0
-9.03%

82,2


66,5


68,8

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
10,5
11,5
-9.12%
3,92
1,44
171.26%
-5,50
-0,83
-563.85%

22,6


2,59


1,13

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
8,57
9,56
-10.41%
4,15
1,62
156.18%
-5,61
-0,48
-1061.08%

23,4


4,08


1,71

Net income
Million USD
Released
Forecast
Spread
8,31
8,12
2.31%
2,93
1,22
140.03%
-6,60
-0,75
-775.28%

19,6


3,79


1,52

EPS
USD
Released
Forecast
Spread
0,09
0,11
-14.29%
0,04
0,02
166.67%
-0,08
-0,01
-1500%

0,24


0,05


0,02

Announcement Date14/03/2417/03/2518/03/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
18,2
18,7
-2.81%
10,1
21,6
-53.18%
15,7
13,5
16.11%
17,9
17,9
-0.08%
9,12
14,4
-36.47%
33,8
11,5
194.3%
19,9
12,9
53.86%

12,4


16,1


15,5


17,5


18,8


20,9

EBIT
Million USD
Released
Forecast
Spread
7,21
4,74
52.22%



1,17
2,20
-46.65%
2,13
4,25
-49.87%
-4,66
0,01
-34603.7%
21,1
-1,42
1587.06%
4,67
-1,32
454.48%

-1,85


-1,38













Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
7,32
4,90
49.26%



0,66
2,53
-73.91%
2,24
4,60
-51.28%
-4,78
0,35
-1468.48%
21,1
-1,14
1951.23%
4,86
-1,02
576.24%

-1,53


-1,06













Net income
Million USD
Released
Forecast
Spread
6,49
4,90
32.49%



0,16
2,38
-93.1%
2,36
4,44
-47%
-5,50
0,21
-2702.36%
18,3
-1,01
1906.41%
3,78
-0,96
491.8%

-1,45


-1,01













EPS
USD
Released
Forecast
Spread
0,09
0,07
28.57%
-0,05
0,08
-162.5%
0,00
0,03
-
0,03
0,06
-45.45%
-0,07
0,01
-1500%
0,22
-0,01
2300%
0,05
-0,01
600%

-0,02


-0,02


0,01


0,01


0,03


0,06

Announcement Date17/03/2509/05/2514/08/2513/11/2518/03/2613/05/2612/08/26------
02/10/2026

Ex-dividend date - 0.63 USD

07:00
02/10/2026

Analyst/Investor Day

08:00
08/10/2026

Ex-dividend date - 0.139 CNY

07:00
08/10/2026

Sales and Revenue Release - Q3 2026

08:00
08/10/2026

Earnings release - Q1 2027

08/10/2026

Earnings presentation

15:30
09/10/2026

Extraordinary General Meeting

09:30
12/10/2026

Earnings presentation

08:00
13/10/2026

Earnings release - Q3 2026

13/10/2026

Earnings presentation

15:30

Past sector events for Protalix BioTherapeutics, Inc.

Today

Information meeting

15:00
Today

Information meeting

30/09/2026

Présentation aux Actionnaires / Analystes

30/09/2026

Annual General Meeting

08:30
30/09/2026

Présentation aux Actionnaires / Analystes

08:30
30/09/2026

Extraordinary General Meeting

09:30
30/09/2026

Présentation aux Actionnaires / Analystes

19:00
30/09/2026

Extraordinary General Meeting

30/09/2026

Annual General Meeting

30/09/2026

Présentation aux Actionnaires / Analystes

08:30

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PLX Stock
  4. PLX Stock
  5. Calendar Protalix BioTherapeutics, Inc.